Fast Metabolic Glycan Labeling for Click-Labeling and Imaging of Sialoglycans in Living Acute Brain Slices from Mice and Human Patients.
Xiaoqian XiaDe-En SunQi TangXianyu LiuXinqi FanYi WanShiyong CuiXu ZhangQingzhu LiuYuwu JiangYe WuBo ChengXing ChenPublished in: Journal of the American Chemical Society (2024)
Living acute brain slices provide a practical platform for imaging sialylation in human brain pathology. However, the limited lifespan of acute brain slices has impeded the use of metabolic glycan labeling (MGL), which requires long-term incubation of clickable unnatural sugars such as N -azidoacetylmannosamine (ManNAz) to metabolically incorporate azides into sialoglycans. Here, we report a fast variant of MGL (fMGL), in which ManNAz-6-phosphate enables efficient azidosugar incorporation within 12 h by bypassing the bottleneck step in the sialic acid biosynthesis pathway, followed by click-labeling with fluorophores and imaging of sialoglycans in acute brain slices from mice and human patients. In the clinical samples of ganglioglioma, fMGL-based imaging reveals specific upregulation of sialylation in astrocyte-like but not neuron-like tumor cells. In addition, fMGL is integrated with click-expansion microscopy for high-resolution imaging of sialoglycans in brain slices. The fMGL strategy should find broad applications in the tissue imaging of glycans and surgical pathology.
Keyphrases
- high resolution
- liver failure
- white matter
- end stage renal disease
- resting state
- endothelial cells
- ejection fraction
- newly diagnosed
- respiratory failure
- chronic kidney disease
- peritoneal dialysis
- drug induced
- functional connectivity
- poor prognosis
- cerebral ischemia
- high throughput
- photodynamic therapy
- multiple sclerosis
- metabolic syndrome
- fluorescence imaging
- blood brain barrier
- skeletal muscle
- insulin resistance
- cell surface
- liquid chromatography